Finance

Lists
YARW:NASDAQ
Yarrow Bioscience Inc
$30.21
+4.71%
(+1.36) 1D
Sep 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for YARW...
Open
$29.34
High
$31.90
Low
$29.04
Mkt. cap
80.65M
Avg. vol.
29.93K
Volume
37.00
52-wk high
$44.28
52-wk low
$26.47
EPS
-$21.85
Beta
2.06
Shares outstanding
2.67M
No. of employees
7
Open
$29.34
High
$31.90
Low
$29.04
Mkt. cap
80.65M
Avg. vol.
29.93K
Volume
37.00
52-wk high
$44.28
52-wk low
$26.47
EPS
-$21.85
Beta
2.06
Shares outstanding
2.67M
No. of employees
7
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
10 hours ago
Responsive Playbooks and the YARW Inflection
About Yarrow Bioscience Inc
CEO-
Employees7
Founded2025
HeadquartersNew Haven, Connecticut, United States
SectorPharmaceutical industry
Analyst ratings
Based on 3 analysts giving stock ratings to YARW in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for YARW in the last 3 months.
Highest
Current $30.21
$58.00 (+91.99%)
Average
$57.00 (+88.68%)
Lowest
$56.00 (+85.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$56.00
+85.4%
08/13/2026
Julian Harrison
BTIG
Buy
Initiated
$58.00
+92%
08/03/2026
Stacy Ku
TD Cowen
Buy
Initiated
-
-
07/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2026
Jun 2026
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
1.25M
4.94M
Total research and development expenses
-
-
Selling, general, and admin expenses
1.62M
1.76M
Operating expense
2.86M
6.70M
Total operating expenses
2.86M
6.70M
Operating income
-2.86M
-6.70M
Other non operating income
-
-
EBT including unusual items
-2.74M
-6.51M
EBT excluding unusual items
-2.74M
-6.51M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-
-
Net income
-2.74M
-6.51M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
117.00K
184.00K
Interest expense
-
-
Net interest expenses
117.00K
184.00K
Depreciation and amortization charges
-
-
EBITDA
-
-
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps